Agnese Losurdo

1.5k total citations
40 papers, 733 citations indexed

About

Agnese Losurdo is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Agnese Losurdo has authored 40 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Agnese Losurdo's work include Breast Cancer Treatment Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and HER2/EGFR in Cancer Research (8 papers). Agnese Losurdo is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and HER2/EGFR in Cancer Research (8 papers). Agnese Losurdo collaborates with scholars based in Italy, United States and Netherlands. Agnese Losurdo's co-authors include Armando Santoro, Giovanna Masci, Rosalba Torrisi, Luca Di Tommaso, Giulia Bottai, Corrado Tinterri, Libero Santarpia, Elisa Agostinetto, Monica Zuradelli and Rita De Sanctis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Agnese Losurdo

39 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnese Losurdo Italy 15 371 249 231 155 123 40 733
Yacine Barèche Belgium 14 600 1.6× 356 1.4× 321 1.4× 249 1.6× 68 0.6× 24 1.0k
Cécile Vicier France 14 465 1.3× 223 0.9× 338 1.5× 122 0.8× 73 0.6× 53 808
Umut H. Toprak Germany 9 223 0.6× 216 0.9× 408 1.8× 50 0.3× 41 0.3× 13 733
Marlies Vanden Bempt Belgium 8 356 1.0× 116 0.5× 299 1.3× 303 2.0× 16 0.1× 9 673
Nadja Zaborsky Austria 18 336 0.9× 93 0.4× 283 1.2× 386 2.5× 69 0.6× 49 945
Kurt D’Andrea United States 14 238 0.6× 235 0.9× 452 2.0× 38 0.2× 197 1.6× 23 872
Stéphanie Lheureux Canada 15 735 2.0× 135 0.5× 331 1.4× 161 1.0× 112 0.9× 46 991
Lisa Giulino‐Roth United States 15 479 1.3× 122 0.5× 411 1.8× 237 1.5× 50 0.4× 39 1.1k
M L Lamelas Spain 11 244 0.7× 283 1.1× 200 0.9× 56 0.4× 27 0.2× 12 547
Fei Fei United States 14 241 0.6× 84 0.3× 227 1.0× 215 1.4× 42 0.3× 46 654

Countries citing papers authored by Agnese Losurdo

Since Specialization
Citations

This map shows the geographic impact of Agnese Losurdo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnese Losurdo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnese Losurdo more than expected).

Fields of papers citing papers by Agnese Losurdo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnese Losurdo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnese Losurdo. The network helps show where Agnese Losurdo may publish in the future.

Co-authorship network of co-authors of Agnese Losurdo

This figure shows the co-authorship network connecting the top 25 collaborators of Agnese Losurdo. A scholar is included among the top collaborators of Agnese Losurdo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnese Losurdo. Agnese Losurdo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Losurdo, Agnese, Angelo Dipasquale, Laura Giordano, et al.. (2024). Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram. Frontiers in Immunology. 15. 1323151–1323151. 1 indexed citations
2.
Dipasquale, Angelo, Agnese Losurdo, Pasquale Persico, et al.. (2023). Brain metastases and next-generation anticancer therapies: a survival guide for clinicians. Critical Reviews in Oncology/Hematology. 194. 104239–104239. 2 indexed citations
3.
Gentile, Damiano, Agnese Losurdo, Andrea Sagona, et al.. (2022). Surgical management of BRCA-mutation carriers: A single institution experience. European Journal of Surgical Oncology. 48(8). 1706–1712. 15 indexed citations
4.
Persico, Pasquale, Elena Lorenzi, Agnese Losurdo, et al.. (2022). Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations. Cancers. 14(5). 1125–1125. 14 indexed citations
5.
Agostinetto, Elisa, Agnese Losurdo, Guilherme Nader Marta, et al.. (2022). Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Expert Opinion on Investigational Drugs. 31(6). 567–591. 65 indexed citations
6.
Simonelli, Matteo, Pasquale Persico, Arianna Capucetti, et al.. (2021). Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes. Neuro-Oncology Advances. 3(1). vdab160–vdab160. 1 indexed citations
7.
Sanctis, Rita De, Laura Giordano, Elisa Agostinetto, et al.. (2021). Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab. The Breast. 57. 80–85. 7 indexed citations
8.
Losurdo, Agnese, Giorgia Alvisi, Jolanda Brummelman, et al.. (2021). Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer. Communications Biology. 4(1). 1117–1117. 18 indexed citations
9.
Torrisi, Rosalba, Emilia Marrazzo, Elisa Agostinetto, et al.. (2021). Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?. Critical Reviews in Oncology/Hematology. 160. 103280–103280. 39 indexed citations
10.
Losurdo, Agnese, Rita De Sanctis, Bethania Fernandes, et al.. (2020). Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice. Scientific Reports. 10(1). 20100–20100. 13 indexed citations
11.
Agostinetto, Elisa, Laura Giordano, Rosalba Torrisi, et al.. (2020). Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer. Clinical Breast Cancer. 20(4). e481–e489. 3 indexed citations
12.
Masci, Giovanna, Elisa Agostinetto, Laura Giordano, et al.. (2020). Prognostic factors and outcome of HER2+ breast cancer with CNS metastases. Future Oncology. 16(7). 269–279. 7 indexed citations
13.
Agostinetto, Elisa, Giovanna Masci, Laura Giordano, et al.. (2019). HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome. Annals of Oncology. 30. iii60–iii60. 2 indexed citations
14.
Torrisi, Rosalba, Monica Zuradelli, Elisa Agostinetto, et al.. (2019). Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?. Critical Reviews in Oncology/Hematology. 135. 66–75. 24 indexed citations
15.
Zuradelli, Monica, Giovanna Masci, Emanuela Ferraro, et al.. (2018). Never too old to fight breast cancer. Medicine. 97(9). e9981–e9981. 2 indexed citations
16.
Losurdo, Agnese, Giuseppe Gullo, Giovanna Masci, et al.. (2017). Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature. Critical Reviews in Oncology/Hematology. 113. 283–291. 36 indexed citations
17.
Bottai, Giulia, Carlotta Raschioni, Agnese Losurdo, et al.. (2016). An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers. Breast Cancer Research. 18(1). 121–121. 91 indexed citations
18.
Bottai, Giulia, Carlotta Raschioni, Agnese Losurdo, et al.. (2016). Abstract P4-04-06: Immune balance between tumor-infiltrating lymphocytes and tumor-associated macrophages impacts the outcome of triple negative breast cancer patients. Cancer Research. 76(4_Supplement). P4–4. 2 indexed citations
19.
Masci, Giovanna, Michele Caruso, Francesco Caruso, et al.. (2015). Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series. The Oncologist. 20(6). 586–592. 58 indexed citations
20.
Torrisi, Rosalba, Carlos A. Garcia‐Etienne, Agnese Losurdo, et al.. (2013). Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: A single institution experience. The Breast. 22(4). 419–424. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yacine Barèche Breakdown of academic impact, for papers by Cécile Vicier Breakdown of academic impact, for papers by Umut H. Toprak Breakdown of academic impact, for papers by Marlies Vanden Bempt Breakdown of academic impact, for papers by Nadja Zaborsky Breakdown of academic impact, for papers by Kurt D’Andrea Breakdown of academic impact, for papers by Stéphanie Lheureux Breakdown of academic impact, for papers by Lisa Giulino‐Roth Breakdown of academic impact, for papers by M L Lamelas Breakdown of academic impact, for papers by Fei Fei
Rankless by CCL
2026